196 related articles for article (PubMed ID: 25603045)
1. Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development.
Maris P; Campana A; Barone I; Giordano C; Morelli C; Malivindi R; Sisci D; Aquila S; Rago V; Bonofiglio D; Catalano S; Lanzino M; Andò S
Endocrinology; 2015 Apr; 156(4):1251-62. PubMed ID: 25603045
[TBL] [Abstract][Full Text] [Related]
2. Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys.
Abiuso AMB; Varela ML; Haro Durand L; Besio Moreno M; Marcos A; Ponzio R; Rivarola MA; Belgorosky A; Pignataro OP; Berensztein E; Mondillo C
Eur J Cancer; 2018 Mar; 91():125-135. PubMed ID: 29367056
[TBL] [Abstract][Full Text] [Related]
3. DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation.
Lanzino M; Maris P; Sirianni R; Barone I; Casaburi I; Chimento A; Giordano C; Morelli C; Sisci D; Rizza P; Bonofiglio D; Catalano S; Andò S
Cell Death Dis; 2013 Jul; 4(7):e724. PubMed ID: 23846226
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth.
Panza S; Malivindi R; Chemi F; Rago V; Giordano C; Barone I; Bonofiglio D; Gelsomino L; Giordano F; Andò S; Catalano S
Am J Pathol; 2016 May; 186(5):1328-39. PubMed ID: 26968343
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
[TBL] [Abstract][Full Text] [Related]
7. Regulation of steroidogenesis and steroidogenic acute regulatory protein in R2C cells by DAX-1 (dosage-sensitive sex reversal, adrenal hypoplasia congenita, critical region on the X chromosome, gene-1).
Jo Y; Stocco DM
Endocrinology; 2004 Dec; 145(12):5629-37. PubMed ID: 15358680
[TBL] [Abstract][Full Text] [Related]
8. Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.
Chimento A; Sirianni R; Zolea F; De Luca A; Lanzino M; Catalano S; Andò S; Pezzi V
J Cell Physiol; 2012 May; 227(5):2079-88. PubMed ID: 21769864
[TBL] [Abstract][Full Text] [Related]
9. WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells.
Gurates B; Sebastian S; Yang S; Zhou J; Tamura M; Fang Z; Suzuki T; Sasano H; Bulun SE
J Clin Endocrinol Metab; 2002 Sep; 87(9):4369-77. PubMed ID: 12213901
[TBL] [Abstract][Full Text] [Related]
10. Insulin directly regulates steroidogenesis via induction of the orphan nuclear receptor DAX-1 in testicular Leydig cells.
Ahn SW; Gang GT; Kim YD; Ahn RS; Harris RA; Lee CH; Choi HS
J Biol Chem; 2013 May; 288(22):15937-46. PubMed ID: 23589295
[TBL] [Abstract][Full Text] [Related]
11. Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.
Catalano S; Malivindi R; Giordano C; Gu G; Panza S; Bonofiglio D; Lanzino M; Sisci D; Panno ML; Andò S
J Biol Chem; 2010 Feb; 285(8):5581-93. PubMed ID: 20026603
[TBL] [Abstract][Full Text] [Related]
12. Aromatase (Cyp19) expression is up-regulated by targeted disruption of Dax1.
Wang ZJ; Jeffs B; Ito M; Achermann JC; Yu RN; Hales DB; Jameson JL
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7988-93. PubMed ID: 11427738
[TBL] [Abstract][Full Text] [Related]
13. Heat stress upregulates aromatases expression through nuclear DAX-1 deficiency in R2C Leydig tumor cells.
Oka S; Matsukuma H; Horiguchi N; Kobayashi T; Shiraishi K
Mol Cell Endocrinol; 2022 Dec; 558():111766. PubMed ID: 36075317
[TBL] [Abstract][Full Text] [Related]
14. Triiodothyronine decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse Sertoli cell line, TM4.
Catalano S; Pezzi V; Chimento A; Giordano C; Carpino A; Young M; McPhaul MJ; Andò S
Mol Endocrinol; 2003 May; 17(5):923-34. PubMed ID: 12586841
[TBL] [Abstract][Full Text] [Related]
15. A steroidogenic factor-1-binding site and cyclic adenosine 3',5'-monophosphate response element-like elements are required for the activity of the rat aromatase promoter in rat Leydig tumor cell lines.
Young M; McPhaul MJ
Endocrinology; 1998 Dec; 139(12):5082-93. PubMed ID: 9832447
[TBL] [Abstract][Full Text] [Related]
16. Detection of aromatase and estrogen receptors (ERalpha, ERbeta1, ERbeta2) in human Leydig cell tumor.
Carpino A; Rago V; Pezzi V; Carani C; Andò S
Eur J Endocrinol; 2007 Aug; 157(2):239-44. PubMed ID: 17656605
[TBL] [Abstract][Full Text] [Related]
17. Role of dosage-sensitive sex reversal, adrenal hypoplasia congenita, critical region on the X chromosome, gene 1 in protein kinase A- and protein kinase C-mediated regulation of the steroidogenic acute regulatory protein expression in mouse Leydig tumor cells: mechanism of action.
Manna PR; Dyson MT; Jo Y; Stocco DM
Endocrinology; 2009 Jan; 150(1):187-99. PubMed ID: 18787026
[TBL] [Abstract][Full Text] [Related]
18. The promoter(s) of the aromatase gene in male testicular cells.
Carreau S; Bourguiba S; Lambard S; Silandre D; Delalande C
Reprod Biol; 2004 Mar; 4(1):23-34. PubMed ID: 15094793
[TBL] [Abstract][Full Text] [Related]
19. Functional assessment of the calcium messenger system in cultured mouse Leydig tumor cells: regulation of human chorionic gonadotropin-induced expression of the steroidogenic acute regulatory protein.
Manna PR; Pakarinen P; El-Hefnawy T; Huhtaniemi IT
Endocrinology; 1999 Apr; 140(4):1739-51. PubMed ID: 10098511
[TBL] [Abstract][Full Text] [Related]
20. TNF-α-mediated suppression of Leydig cell steroidogenesis involves DAX-1.
Sadasivam M; Ramatchandirin B; Balakrishnan S; Prahalathan C
Inflamm Res; 2015 Jul; 64(7):549-56. PubMed ID: 26047595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
